MYKRONOR

This brand name is authorized in Ireland, Romania.

Active ingredients

The drug MYKRONOR contains one active pharmaceutical ingredient (API):

1	Noradrenaline tartrate UNII IFY5PE3ZRW - NOREPINEPHRINE BITARTRATE
	Noradrenaline provides a strong stimulation of alpha receptors in blood vessels at which these are counter-extracted. Noradrenaline also has an effect on beta-1 receptors in the heart leading to a positive inotropic and initially positive chronotropic effect. The increase in blood pressure may cause a reflex reduction in heart rate.
	Read more about Noradrenaline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYKRONOR Solution for injection / infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01CA03	Norepinephrine	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CA Adrenergic and dopaminergic agents
Discover more medicines within C01CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68373001, W68373002